Skip to content
Menu

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $121

Benzinga Newsdesk 3 days ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.

Read at benzinga.com